Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Artificial Intelligence in Diabetic Eye Disease Screening

Artificial Intelligence in Diabetic Eye Disease Screening Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/03/2020 REVIEW ARTICLE Carol Y. Cheung, PhD,* Fangyao Tang, PhD,* Daniel Shu Wei Ting, MD, PhD,† Gavin Siew Wei Tan, MD,† and Tien Yin Wong, MD, PhD† 7–9 10,11 age-related macular degeneration (AMD), glaucoma, and Abstract: Systematic or national screening programs for diabetic 12,13 retinopathy of prematurity, as well as the segmentation and retinopathy (DR) and diabetic macular edema (DME), using digital assessment of optical coherence tomography (OCT) images for fundus photography and optical coherence tomography (OCT), are 14–16 diagnosis and screening of major retinal diseases. currently implemented at primary care level, aiming to provide timely For DR screening, DL has made remarkable breakthrough referral for vision-threatening DR and DME to ophthalmologists for with some of the first few landmark studies in this area, as timely treatment and vision loss prevention. However, interpretation of well as approval and registration of a fundus camera device for retinal images requires specialized knowledge and expertise in diabetic DR screening using DL technology by the US Food and Drug eye disease. Furthermore, current DR screening programs are capital- and 17 Administration (FDA). A study by Google Health, in particular, labor-intensive, which makes it difficult to rapidly scale http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/artificial-intelligence-in-diabetic-eye-disease-screening-XOTvOsFdJC

References (59)

Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.22608/APO.201976
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/03/2020 REVIEW ARTICLE Carol Y. Cheung, PhD,* Fangyao Tang, PhD,* Daniel Shu Wei Ting, MD, PhD,† Gavin Siew Wei Tan, MD,† and Tien Yin Wong, MD, PhD† 7–9 10,11 age-related macular degeneration (AMD), glaucoma, and Abstract: Systematic or national screening programs for diabetic 12,13 retinopathy of prematurity, as well as the segmentation and retinopathy (DR) and diabetic macular edema (DME), using digital assessment of optical coherence tomography (OCT) images for fundus photography and optical coherence tomography (OCT), are 14–16 diagnosis and screening of major retinal diseases. currently implemented at primary care level, aiming to provide timely For DR screening, DL has made remarkable breakthrough referral for vision-threatening DR and DME to ophthalmologists for with some of the first few landmark studies in this area, as timely treatment and vision loss prevention. However, interpretation of well as approval and registration of a fundus camera device for retinal images requires specialized knowledge and expertise in diabetic DR screening using DL technology by the US Food and Drug eye disease. Furthermore, current DR screening programs are capital- and 17 Administration (FDA). A study by Google Health, in particular, labor-intensive, which makes it difficult to rapidly scale

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Mar 1, 2019

There are no references for this article.